Article

jdsupra.com on 2020-02-25 18:51

Not So Clean After All: FDA Takes Aim at Manufacturer of OTC Hand Sanitizer Product Line Making Disease Prevention Claims from Ebola to the Flu

With everyone worrying about the coronavirus and the flu this time of year, it is not surprising that last month the Food and Drug Administration ...

Related news

FDA Shuts Down OTC Drug Manufacturer with Longstanding and Pervasive cGMP and Labeling Issues jdsupra.com
California , United States , Switzerland
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer jdsupra.com
California , United States , Switzerland
FDA Issues Final Guidance Documents Relating to Medical Product Manufacturer Communications jdsupra.com
California , United States , Switzerland
Drug test manufacturer seeking FDA approval for new product bizjournals.com
New Jersey , United States
FDA Issues Guidance on Drug and Device Manufacturer Communications: Part II – Medical Product Communications that are Consistent with the FDA-Required Labeling jdsupra.com
California , United States , Switzerland
FDA proposes streamlining combination product regulations jdsupra.com
California , United States , Switzerland
FDA Finalizes New Definition of Biological Product jdsupra.com
California , United States , Switzerland
FDA Guidance on DSCSA Product Identifier Requirements jdsupra.com
California , United States , Switzerland
FDA Issues Final Definition for “Biological Product”jdsupra.com
California , United States , Switzerland
FDA and TTB Take Steps to Ease Hand Sanitizer Shortage jdsupra.com
California , United States , Switzerland
FDA Issues Temporary Policy to Address Hand Sanitizer Shortage jdsupra.com
California , United States , Switzerland
Lessons From FDA’s Warning Letter to Stem Cell Product Manufacturer jdsupra.com
California , United States , Switzerland
FDA Chief of Staff: OTC reform remains “top priority” for FDA jdsupra.com
California , United States , Switzerland
FDA Will Publish Proposed Rule for OTC Sunscreen Drug Products jdsupra.com
California , United States , Switzerland
FDA Releases New Enforcement Policy for OTC Sunscreen Drug Products Marketed Without an Approved Application jdsupra.com
California , United States , Switzerland
Curaleaf Responds to FDA Warning Over CBD Product Marketing jdsupra.com
California , United States , Switzerland
Product Recall – Proof of Responsible Manufacturer Not Defect jdsupra.com
California , United States , Switzerland
Cannabis Infused-Product Manufacturer Cited By Cal/OSHA jdsupra.com
California , United States , Switzerland
FDA, FTC Warn CBD Maker Over Product Claims jdsupra.com
California , United States , Switzerland
FDA Extends Compliance Period for Wholesalers to Verify Returned Product jdsupra.com
California , United States , Switzerland